Epidemic Outbreaks in Plovdiv Region (Bulgaria) of Vaccine-Preventable Diseases: Measles, Mumps, Hepatitis A


Aim: To analyze the reasons for epidemic outbreaks of measles, mumps and viral hepatitis A and to propose measures to prevent them in future. Materials and methods: Тhe incidence of measles, mumps and hepatitis A in Plovdiv region was studied for the period 2006-2010. An analysis of the age structure of the patients was made, while taking into account the time for routine immunization performed against measles and mumps (first and second dose). Results: In 2006-2009 single cases of measles were found occasionally, but in 2010 they were 2787 (incidence 395/100,000). Most of them (51%) were for ages 13 months-12years, 27%-0-13 months and 11%-13 to 18 years. The incidence of mumps for 2006-2010 varied widely, and has increased significantly in 2007 (130/100,000) and 2008 (169/100,000). The majority of patients (over 34%) during the epidemics were aged 13 months-12years, and over 26% of them-13-19 years. For the period 2006-2010 the incidence of hepatitis A ranged from 2.98/100, 000 (2009) to 426/100,000 (2006). Over 50% of the cases involved children aged up to 9 years. For the three diseases over 80% of patients were individuals of Roma origin. Conclusions: 1. Epidemic spread of measles in 2010 was mainly due to shortcomings in the routine immunization carried as a prevention of the disease. 2. There are two reasons for the outbreak of mumps: А) Failure to administer the second vaccine dose at 12 years in Bulgaria until 2001. B) Shortcomings in routinely performed immunization. 3. The extremely high incidence of hepatitis A in 2006 (and in the rest of the years) is due to the lack of routine immunization. 4. Essential for the outbreaks in all three diseases are the poor hygienic living conditions, the low social status and the lack of health promotion of the population at risk 5. To prevent future outbreaks of the diseases hereby in question, we suggest it is appropriate: А) To introduce compulsory immunization against hepatitis A; B) To carry out periodic catch-up vaccination campaigns against measles and mumps.

Share and Cite:

N. Vatev, M. Stoycheva, A. Petrov and R. Velcheva, "Epidemic Outbreaks in Plovdiv Region (Bulgaria) of Vaccine-Preventable Diseases: Measles, Mumps, Hepatitis A," World Journal of Vaccines, Vol. 2 No. 3, 2012, pp. 172-177. doi: 10.4236/wjv.2012.23023.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] D. Waku-Kouomou, F. Freymuth, I. P. du Chatelet, T. F. Wild and B. Horvat, “Co-Circulation of Measles Virus Genotypes during an Epidemic in France in 2008,” Journal of Medical Virology, Vol. 82, No. 6, 2010, pp. 1033-1043. doi:10.1002/jmv.21766
[2] S. Gee, S. Cotter and D. O. Flanagan, “Spotlight on Measles 2010: Measles Outbreak in Ireland,” Eurosurveillance, Vol. 15, No. 3, 2010, pii=19500.
[3] H. Roggendorf, A. Mankertz, R. Kundt and M. Roggendorf, “Spotlight on Measles 2010: Measles Outbreak in a Mainly Unvaccinated Community in Essen, Germany, March-June 2010,” Eurosurveillance, Vol. 15, No. 26, 2010, pii=19605.
[4] H. Ortikova, J. Rogalska, E. Kazanovska-Zielinska, T. Jankovski, J. Stodzinski, B. Kass and P. Stefanoff, “Spotlight on Measles 2010: A Measles Outbreak in a Roma Population in Pulawy, Eastern Poland, June to August 2009,” Eurosurveillance, Vol. 15, No 17, 2010, pii= 19550.
[5] N. Siegfried, C. Wlisong and D. Pienaar, “Too Little, Too Late: Measles Epidemic in South Africa,” The Lancet, Vol. 376, No. 9736, 2010, p. 160. www.thelancet.com
[6] D. Pervanidu, E. Horefti, S. Patrinos, T. Lytras, E. Triantafillou, A. Mentis, S. Bonavas and T. Panagiotopoulos, “Spotlight on Measles 2010: Ongoing Measles Outbreak in Greece, January-July 2010,” Eurosurveillance, Vol. 15, No. 30, 2010, pii=19629.
[7] C. S. Moyer, “Mumps Immunity Falls below Optimal Level,” American Medical News, 2010. amednews.com
[8] J. Whelan, R. van Binnendijk, K. Greenland, E. Fanoy, M. Khargi, K. Yap, H. Boot, N. Veltman, C. Swaan, A. van der Bij, H. de Melker and S. Hahné, “Ongoing Mumps Outbreak in a Student Population with High Vaccination Coverage, Netherlands, 2010,” Eurosurveillance, Vol. 15, No. 17, 2010, pii=19554.
[9] W. Otto, A. Mankertz, S. Santibanez, H. Saygili, J. Wenzel, W. Jilg, W. F. Wieland and S. Borgmann, “Ongoing Outbreak of Mumps Affecting Adolescents and Young Adults in Bavaria, Germany, August to October 2010,” Eurosurveillance, Vol. 15, No. 50, 2010, pii= 19748.
[10] G. Kuzmanovska, A. Polozhani, V. Mikik, K. Stavridis, B. Aleksoski, Z. Cvetanovska, R. Binnendijk and G. Bosevska, “Mumps Outbreak in the Former Yugoslav Republic of Macedonia, January 2008-June 2009: Epidemiology and Control Measures,” Eurosurveillance, Vol. 15, No. 23, 2010, pii=19586.
[11] C. Stein-Zamir, H. Shoob, N. Abramson, E. Tallen-Gozani, I. Sokolov and G. Zentner, “Mumps Outbreak in Jerusalem Affecting Mainly Male Adolescents,” Eurosurveillance, Vol. 14, No. 50, 2009, pii=19440.
[12] J. Cástková and C. Bene?, “Increase in hepatitis A cases in the Czech Republic in 2008—Update,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19091.
[13] J. Perevoscikovs, I. Lucenko, S. Magone, A. Brila, J. Curikova and H. Vennema, “Community-Wide Outbreak of Hepatitis A in Latvia in 2008—An Update,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19092.
[14] L. Hrivniaková, M. Slá?iková and S. Kolcunová, “Hepatitis A Outbreak in a Roma Village in Eastern Slovakia, August-November 2008,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19093.
[15] E. Couturier, A. M. Roque-Afonso, M. J. Letort, E. Dussaix, V. Vaillant and H. de Valk, “Cluster of Cases of Hepatitis A with a Travel History to Egypt, September-November 2008, France,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19094.
[16] E. Robesyn, M. I. Micalessi, S. Quoilin, M. Naranjo and I. Thomas, “Cluster of Hepatitis A Cases among Travellers Returning from Egypt, Belgium, September through November 2008,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19095.
[17] H. Bernard and C. Frank, “Cluster of Hepatitis A Cases among Travellers Returning from Egypt, Germany, September through November 2008,” Eurosurveillance, Vol. 14, No. 3, 2009, pii=19096.
[18] European Centre for Disease Prevention and Control (ECDC), “Epidemiological Update on Measles in EU/ EEA,” ECDC, Stockholm, 2011. http://www.ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f%2D77d4%2D4ad8%2Db6d6%2Dbf0f23083f30&ID=1046&Source=http%3A%2F%2Fwww%2Eecdc%2Eeuropa%2Eeu%2Fen%2Factivities%2Fsciadvice%2FLists%2FECDC%2520Reviews%2Fall%2520items%2Eaps
[19] A. P. Fiebelkorn, S. B. Redd, K. Gallagher, P. A. Rota, J. Rota, W. Bellini and J. Seward, “Measles in the United States during the Postelimination Era,” Journal of Infectious Diseases, Vol. 202, No. 10, 2010, pp. 1520-1528. doi:10.1086/656914
[20] J. C. Nmor, H. T. Thanh and K. Goto, “Recurring Measles Epidemic in Vietnam 2005-2009: Implication for Strengthened Control Strategies,” International Journal of Biological Sciences, Vol. 7, No. 2, 2011, pp. 138-146. doi:10.7150/ijbs.7.138
[21] M. Karcheva, “Mumps—Epidemiology,” Ph. D. Dissertation, Medical University, Pleven, 2010 (in Bulgarian).

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.